Cargando…
2008. Outcomes of Patients with Positive Procalcitonin Levels Who Do Not Receive Continued Antibiotics
BACKGROUND: Procalcitonin (PCT) is a biomarker used to direct continued use of antibiotic therapy in patients with sepsis and community-acquired pneumonia. There is a lack of data on outcomes of patients with a positive PCT who do not receive continued antibiotics. We compared outcomes in patients w...
Autores principales: | George, Jamie, Kale-Pradhan, Pramodini, Johnson, Leonard B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808812/ http://dx.doi.org/10.1093/ofid/ofz360.1688 |
Ejemplares similares
-
2428. Lower Rates of Antibiotic Treatment of Vancomycin-Resistant Compared With Vancomycin Susceptible Enterococcal Bacteriuria
por: Vendittelli, Bridget, et al.
Publicado: (2018) -
1469. Effect of Treatment Duration on Outcomes in Septic Patients Admitted for Urinary Tract Infections from Extended Care Facilities
por: Jongekrijg, Annelise, et al.
Publicado: (2019) -
Effectiveness of Daptomycin in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Vancomycin
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2017) -
49. Clinical Utility of Oseltamivir Restriction Policy
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2020) -
1386. Prescribing Patterns of Skin and Soft Tissue Infections in Patients Discharged from the Emergency Department
por: Feist, Jacqueline, et al.
Publicado: (2022)